These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21828185)

  • 1. The P2Y(6) receptor stimulates bone resorption by osteoclasts.
    Orriss IR; Wang N; Burnstock G; Arnett TR; Gartland A; Robaye B; Boeynaems JM
    Endocrinology; 2011 Oct; 152(10):3706-16. PubMed ID: 21828185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.
    Syberg S; Brandao-Burch A; Patel JJ; Hajjawi M; Arnett TR; Schwarz P; Jorgensen NR; Orriss IR
    J Bone Miner Res; 2012 Nov; 27(11):2373-86. PubMed ID: 22714653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells.
    Hoebertz A; Meghji S; Burnstock G; Arnett TR
    FASEB J; 2001 May; 15(7):1139-48. PubMed ID: 11344082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.
    Wang N; Robaye B; Agrawal A; Skerry TM; Boeynaems JM; Gartland A
    Mol Endocrinol; 2012 Jan; 26(1):142-52. PubMed ID: 22108801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
    Solgaard M; Jørgensen NR
    Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone phenotypes of P2 receptor knockout mice.
    Orriss I; Syberg S; Wang N; Robaye B; Gartland A; Jorgensen N; Arnett T; Boeynaems JM
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1038-46. PubMed ID: 21622253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption.
    Ke HZ; Qi H; Weidema AF; Zhang Q; Panupinthu N; Crawford DT; Grasser WA; Paralkar VM; Li M; Audoly LP; Gabel CA; Jee WS; Dixon SJ; Sims SM; Thompson DD
    Mol Endocrinol; 2003 Jul; 17(7):1356-67. PubMed ID: 12677010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.
    Buckley KA; Hipskind RA; Gartland A; Bowler WB; Gallagher JA
    Bone; 2002 Nov; 31(5):582-90. PubMed ID: 12477572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.
    Malmsjö M; Hou M; Pendergast W; Erlinge D; Edvinsson L
    Eur J Pharmacol; 2003 Jan; 458(3):305-11. PubMed ID: 12504787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration.
    Pillois X; Chaulet H; Belloc I; Dupuch F; Desgranges C; Gadeau AP
    Circ Res; 2002 Apr; 90(6):678-81. PubMed ID: 11934835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
    Sasaki T
    Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.
    Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR
    Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2 receptor expression, signaling and function in osteoclasts.
    Reyes JP; Sims SM; Dixon SJ
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1101-18. PubMed ID: 21622259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced trabecular bone resorption and microstructural bone changes in rats after removal of the cecum.
    Charoenphandhu N; Suntornsaratoon P; Jongwattanapisan P; Wongdee K; Krishnamra N
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1069-75. PubMed ID: 22912366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate.
    Malmsjö M; Hou M; Harden TK; Pendergast W; Pantev E; Edvinsson L; Erlinge D
    J Pharmacol Exp Ther; 2000 Jun; 293(3):755-60. PubMed ID: 10869373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.
    Warny M; Aboudola S; Robson SC; Sévigny J; Communi D; Soltoff SP; Kelly CP
    J Biol Chem; 2001 Jul; 276(28):26051-6. PubMed ID: 11349132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.